ArticleHepatology communications2026

A novel cell-permeable LOXL2 inhibitor PAT-1251 potently suppresses biliary liver fibrosis via collagen crosslinking-dependent and -independent mechanisms.

Ping An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.